Estudo multicŒntrico comparativo entre Felodipina e Captopril como monoterapia em pacientes com hipertensªo leve a moderada
暂无分享,去创建一个
Agostinho Tavares | Artur Beltrame Ribeiro | W. Oigman | Mariângela Zanella | N. Spritzer | P. César | Seide Abdala
[1] E. Bravo. Individualizing drug therapy for the hypertensive patient. , 1995, Hospital practice.
[2] B. Edgar,et al. Felodipine Clinical Pharmacokinetics , 1991, Clinical pharmacokinetics.
[3] B. Magnani,et al. Long-term antihypertensive, metabolic and cellular effects of enalapril. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[4] R. Cooper. Captopril-associated neutropenia. Who is at risk? , 1983, Archives of internal medicine.
[5] R. Tarazi,et al. Converting Enzyme Inhibition with an Orally Active Compound in Hypertensive Man , 1979, Hypertension.
[6] R. Cody,et al. Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients. , 1978, Clinical science and molecular medicine.
[7] D. Faulds,et al. Felodipine , 2012, Drugs.
[8] G. Balice,et al. A comparison between two different dosages of felodipine extended release and captopril in the treatment of mild to moderate hypertension , 1991 .
[9] M. Weinberger. Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. , 1985, Journal of cardiovascular pharmacology.
[10] F. Dunn,et al. Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. , 1984, The American journal of cardiology.